CAIRO PHARMACEUTICALSCAIRO PHARMACEUTICALSCAIRO PHARMACEUTICALS

CAIRO PHARMACEUTICALS

No trades
See on Supercharts
Market capitalization
‪1.50 B‬EGP
‪4.48 M‬
Beta (1Y)
0.54

About CAIRO PHARMACEUTICALS


CEO
Yasser Ahmed Farghaly Mohammad
Headquarters
Cairo
Founded
1962
ISIN
EGS38391C016
FIGI
BBG000BYC5G0
Cairo Pharmaceuticals engages in the manufacture and distribution of pharmaceutical products for human and veterinary use, cosmetics and pesticides, and other chemical substances and related products. Its products include analgesics, antibiotics, antidepressants, antihistamines, dermatological, endocrine drugs, gastrointestinal drugs, ophthalmic, pulmonic, and urinary antiseptics. The company was founded in 1962 and is headquartered in Cairo, Egypt.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CPCI is 104.010 EGP — it has increased by 1.46% in the past 24 hours. Watch CAIRO PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange CAIRO PHARMACEUTICALS stocks are traded under the ticker CPCI.
CPCI stock has risen by 1.10% compared to the previous week, the month change is a 20.82% rise, over the last year CAIRO PHARMACEUTICALS has showed a 77.22% increase.
CPCI reached its all-time high on Oct 28, 2024 with the price of 111.000 EGP, and its all-time low was 6.637 EGP and was reached on May 15, 2001. View more price dynamics on CPCI chart.
See other stocks reaching their highest and lowest prices.
CPCI stock is 4.04% volatile and has beta coefficient of 0.54. Track CAIRO PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is CAIRO PHARMACEUTICALS there?
Today CAIRO PHARMACEUTICALS has the market capitalization of ‪1.50 B‬, it has decreased by −0.02% over the last week.
Yes, you can track CAIRO PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
CPCI net income for the last quarter is ‪74.55 M‬ EGP, while the quarter before that showed ‪61.35 M‬ EGP of net income which accounts for 21.53% change. Track more CAIRO PHARMACEUTICALS financial stats to get the full picture.
Yes, CPCI dividends are paid annually. The last dividend per share was 5.00 EGP. As of today, Dividend Yield (TTM)% is 4.98%. Tracking CAIRO PHARMACEUTICALS dividends might help you take more informed decisions.
Like other stocks, CPCI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CAIRO PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CAIRO PHARMACEUTICALS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CAIRO PHARMACEUTICALS stock shows the buy signal. See more of CAIRO PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.